Each quarter, we monitor the progress of our generic partners in developing, filing and selling MPP’s licensed medicines, in countries where access could not have been possible without our work.
Discover
Prioritisation of medicines ensures that MPP focuses its efforts on interventions for which such mechanism could have the greatest public health impact.
The core work of the Medicines Patent Pool involves negotiating public health-driven licences with originators, then sublicensing to generic manufacturers and product developers, and supporting access to treatments in low- and middle-income countries (LMICs).
Enabling access to affordable medicines for those who need them most, wherever they live, is MPP’s contribution to achieve Universal Health Coverage.
Hear from some of our partners on what they have to say about our work.
From sales of medicines to impact on peoples’ lives, the Medicines Patent Pool’s work is a game-changer in the access to treatments space.